| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Nektar Therapeutics (NKTR) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 14 sells. NKTR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 75.9K | $5.06M | - | |
| Other | 21.6K | $1.44M | - | |
| Other | 15.4K | $1.03M | -5,538 | |
| Dir | 8.0K | $533.5K | - | |
| Dir | 8.0K | $533.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 16, 2019 | Labrucherie Gil M84 | SVP &Chief Financial Officer | Sell | 5,063 | $18.15 | $91,893.45 | -4.0% | |
| Aug 16, 2019 | Doberstein Stephen K | SVP &Chief Scientific Officer | Sell | 3,245 | $18.15 | $58,896.75 | -3.4% | |
| Aug 14, 2019 | Labrucherie Gil M84 | SVP &Chief Financial Officer | Sale+OE | 25,000 | $17.79 | $444,750.00 | -16.3% | |
| Jul 25, 2019 | Robin Howard W58 | President &CEO | Sale+OE | 100,000 | $31.29 | $3,128,667.49 | -10.1% | |
| Jul 10, 2019 | Labrucherie Gil M84 | SVP &Chief Financial Officer | Sale+OE | 25,000 | $34.57 | $864,250.00 | -16.3% | |
| Jul 8, 2019 | Lingnau Lutz | Director | Sale+OE | 10,000 | $34.63 | $346,300.00 | -30.1% | |
| Jun 17, 2019 | Labrucherie Gil M84 | SVP &Chief Financial Officer | Sale+OE | 25,000 | $33.71 | $842,750.00 | -16.3% | |
| May 23, 2019 | Robin Howard W58 | President &CEO | Sale+OE | 100,000 | $33.00 | $3,300,000.38 | -10.1% | |
| May 16, 2019 | Thomsen Jillian B.86 | SVP &Chief Accounting Officer | Sell | 1,928 | $31.37 | $60,481.36 | -1.2% | |
| May 16, 2019 | Robin Howard W58 | President &CEO | Sell | 13,383 | $31.37 | $419,824.71 | -4.3% |